Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01416337 · ClinicalTrials.gov registry record · Phase 1
Absolute Bioavialability of GSK1120212
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT01416337 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 6 participants.
The verdict
NCT01416337, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
A Phase I, single-center, open-label, single-persiod, combined single dose oral and IV microtracer study in subjects with solid tumors.
Interventions
- DRUG GSK1120212
- DRUG GSK1120212B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2011-06-20 |
| Est. Completion | 2011-12-17 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01416337
The ClinicalTrials.gov registry entry for NCT01416337 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which GSK1120212 is the first listed.
NCT01416337 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01416337 about?
NCT01416337 is a clinical study titled "Absolute Bioavialability of GSK1120212". A Phase I, single-center, open-label, single-persiod, combined single dose oral and IV microtracer study in subjects with solid tumors.
What is the current status of trial NCT01416337?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2011-06-20. Estimated completion is 2011-12-17.
What interventions are being tested in trial NCT01416337?
The interventions under investigation include: GSK1120212 (DRUG), GSK1120212B (DRUG).
Who is sponsoring clinical trial NCT01416337?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.